United States Urinary Catheters Market is expected to reach US$ 6.59 billion by 2033 | Top 3 key players - B. Braun Melsungen AG, Coloplast A/S, BD (Becton, Dickinson and Company).

Market Size and Growth:

The Urinary Catheters Market size reached US$ 3.90 billion in 2024 and is expected to reach US$ 6.59 billion by 2033, growing at a CAGR of 6.04% during the forecast period 2025-2033. The Market is growing due to the rising prevalence of urinary disorders, increasing geriatric population, and expanding hospital and home healthcare services worldwide.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/urinary-catheters-market?sz

The Urinary Catheters Market encompasses the global demand, production, and sales of medical devices used to drain urine from the bladder. These catheters, including intermittent, indwelling, and external types, serve patients with urinary retention, incontinence, or post-surgical needs. Market growth is driven by rising geriatric populations, chronic diseases, technological innovations, and increasing hospital and home healthcare applications.

Industry Recent Developments:

United States:

✅ July 2025: The U.S. urinary catheters market is projected to experience sustained growth driven by rising incidences of disorders such as benign prostate hyperplasia, urinary retention, bladder cancer, and overactive bladder in the aging population. The market size was USD 2.33 billion in 2024 and expected to grow steadily through 2034 at a CAGR of 3.6%.

✅ August 2025: Advances in catheter technology including antimicrobial coatings and biocompatible materials are enhancing patient safety and comfort, leading to greater adoption of specialized catheters like Foley and intermittent catheters in clinical settings.

✅ August 2025: Segment-wise, intermittent catheters are the largest revenue-generating products, while external catheters are registering the fastest growth within the U.S. market. The market is forecasted to reach USD 2.31 billion by 2030 with a CAGR of 4.8%.

Japan:

✅ August 2025: The Japan urinary catheters market generated USD 336.3 million in 2023 and is expected to grow at a CAGR of 6.1% through 2030. Intermittent catheters are also the largest revenue-generating segment, and external catheters show the fastest growth.

✅ August 2025: The catheter market in Japan is driven by a growing need for medical devices to address age-related health conditions such as urinary incontinence, diabetes, and cardiovascular diseases, with market value expected to increase from USD 1.1 billion in 2024 to USD 1.8 billion by 2033 at a CAGR of 5.35%.

✅ Recent cultural and healthcare trends in Japan show increased awareness and acceptance of intermittent catheters for urinary retention management, supported by healthcare providers' educational efforts and investment in advanced medical technologies.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/urinary-catheters-market?sz

Major 5 Key Players:

1. B. Braun Melsungen AG
Headquarters: Melsungen, Germany

Overview: Founded in 1839, B. Braun is a leading global medical technology company specializing in a wide range of healthcare solutions.

Key Products: The Actreen® product line offers solutions for male, female, and pediatric self-catheterization, focusing on comfort and user-friendliness.

Market Position: B. Braun is recognized for its extensive range of urinary catheters, including intermittent, indwelling, and suprapubic types, and is a prominent player in the global catheter market.

2. Coloplast A/S
Headquarters: Humlebæk, Denmark

Overview: Established in 1957, Coloplast is a global medical device company specializing in products related to ostomy care, urology, continence care, and wound care.

Key Products: Coloplast's SpeediCath® and Self-Cath® closed systems are designed to simplify self-catheterization while maintaining high hygiene standards.

Market Position: Coloplast is known for promoting patient comfort and independence by providing easy-to-use, ready-to-use solutions for bladder management and urological care.

3. BD (Becton, Dickinson and Company)
Headquarters: Franklin Lakes, New Jersey, USA

Overview: Founded in 1897, BD is a leading global medical technology company that develops, manufactures, and sells medical devices, instrument systems, and reagents.

Key Products: BD offers a range of urinary catheters, including polyurethane ureteral catheters designed for efficient ureteral access, offering flexibility, smooth shafts, and color-coded ends for easy identification.

Market Position: BD's catheters are radiopaque, sterile, and available in various sizes and configurations to ensure patient comfort and precision during medical procedures.

4. Hollister Incorporated
Headquarters: Libertyville, Illinois, USA

Overview: Hollister is a global medical device company that develops, manufactures, and markets healthcare products related to ostomy care, continence care, and critical care.

Key Products: Hollister offers a variety of urinary catheters, including intermittent catheters designed for ease of use and patient comfort.

Market Position: Hollister is recognized for its commitment to providing high-quality healthcare products that improve the quality of life for individuals with medical conditions requiring catheterization.

5. Medtronic PLC
Headquarters: Dublin, Ireland

Overview: Medtronic is a global leader in medical technology, services, and solutions, offering a broad range of innovative products and therapies.

Key Products: Medtronic provides a variety of urinary catheters, including those designed for specific medical procedures and patient needs.

Market Position: Medtronic's extensive product portfolio and global reach make it a significant player in the urinary catheters market.

FDA Approvals in 2025:

1. Gemcitabine Intravesical System (Inlexzo)
On September 9, 2025, the FDA approved Inlexzo (formerly TAR-200), a gemcitabine intravesical system by Janssen Biotech. This device is co-packaged with a urinary catheter and stylet, designed for patients with Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors. Clinical trials indicated an 82% complete response rate, with 51% of patients maintaining complete response for at least one year.

2. Mitomycin Intravesical Solution (Zusduri)
On June 12, 2025, UroGen Pharma's Zusduri, a mitomycin intravesical solution, was approved for adult patients with recurrent low-grade intermediate-risk NMIBC. This approval offers a new treatment option for patients with this condition.

3. FDA Approvals in Urology (First Half of 2025)
The first half of 2025 saw several FDA approvals in urology, including advancements in bladder cancer, prostate cancer, and incontinence treatments. These approvals reflect ongoing innovation in the field.

Mergers & Acquisitions:
1. ConvaTec Acquires 180 Medical
In September 2025, ConvaTec acquired 180 Medical, a supplier of urinary catheters and ostomy equipment. This acquisition enhances ConvaTec's position in the urology and ostomy care markets.

2. Teleflex Announces Business Separation
Teleflex announced plans to separate into two publicly traded companies. One entity will focus on urology, acute care, and OEM businesses, while the other will concentrate on vascular access, interventional, and surgical businesses.

3. MedTech M&A Activity
The MedTech industry experienced significant mergers and acquisitions in 2025, with companies like Stryker, Boston Scientific, and NAMSA expanding their portfolios in interventional devices, digital testing, and clinical research.

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=urinary-catheters-market

Segments Covered in the Urinary Catheters Market:

1. By Product Type
Intermittent Catheters: Designed for temporary use; inserted and removed several times a day. Popular for patients with neurogenic bladder or urinary retention.

Indwelling Catheters (Foley Catheters): Left inside the bladder for continuous drainage, often used in hospitalized or long-term care patients.

External Catheters: Non-invasive, mainly for men; fits over the drains urine externally into a bag.

Specialty Catheters: Include antibiotic-coated, hydrophilic, or other advanced catheters designed to reduce infection risk or improve patient comfort.

2. By Material
Silicone: Hypoallergenic, long-term use, reduces infection risk.

Latex: Flexible, cost-effective, but may cause allergic reactions.

PVC/Plastic: Disposable and low-cost, used mainly for short-term applications.

3. By Usage
Hospital Use: Catheters used in surgeries, critical care, or long-term hospitalized patients.

Homecare Use: Catheters used by patients at home for chronic conditions or post-surgery recovery.

4. By End User
Hospitals & Clinics: Major consumers due to surgeries and inpatient care.

Homecare Settings: Growing segment as more patients manage urinary issues at home.

Ambulatory Surgical Centers: Increasing demand due to outpatient procedures.

5. By Geography
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa: Different regions show growth based on healthcare infrastructure, awareness, and chronic disease prevalence.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Urinary Catheters Market in 2025?
◆ What is the projected growth rate of the Urinary Catheters Market through 2033?
◆ Who are the key players in the Urinary Catheters Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.